Yumi Jimbu

699 total citations
24 papers, 566 citations indexed

About

Yumi Jimbu is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Yumi Jimbu has authored 24 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Surgery. Recurrent topics in Yumi Jimbu's work include Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Diabetes Treatment and Management (5 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). Yumi Jimbu is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Diabetes Treatment and Management (5 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). Yumi Jimbu collaborates with scholars based in Japan, United States and China. Yumi Jimbu's co-authors include Takeo Kato, Hiroshi Yamaguchi, Makoto Daimon, Makoto Tominaga, Toshihide Oizumi, Wataru Kameda, Masahiko Igarashi, Akihiko Hirata, Hiroshi Ohnuma and Shinji Susa and has published in prestigious journals such as Diabetes Care, Biochemical and Biophysical Research Communications and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Yumi Jimbu

24 papers receiving 556 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yumi Jimbu Japan 16 219 158 112 110 88 24 566
Kikuko Amo Japan 7 276 1.3× 221 1.4× 147 1.3× 153 1.4× 144 1.6× 9 765
Mizuko Osaka Japan 13 214 1.0× 91 0.6× 120 1.1× 96 0.9× 168 1.9× 23 688
Laura A. Villalobos Spain 8 190 0.9× 153 1.0× 101 0.9× 76 0.7× 114 1.3× 8 613
Cecilia Vitali United States 9 153 0.7× 166 1.1× 94 0.8× 258 2.3× 64 0.7× 25 567
Richard Reneland Sweden 17 355 1.6× 206 1.3× 171 1.5× 154 1.4× 154 1.8× 29 929
Danielle Lann United States 8 212 1.0× 182 1.2× 110 1.0× 67 0.6× 121 1.4× 10 512
Taishan Zheng China 14 344 1.6× 207 1.3× 83 0.7× 214 1.9× 61 0.7× 32 662
Dalia El-Lebedy Egypt 12 98 0.4× 95 0.6× 91 0.8× 71 0.6× 86 1.0× 29 453
Naoyuki Iso-O Japan 16 399 1.8× 111 0.7× 134 1.2× 223 2.0× 78 0.9× 25 738
Leonardo Gómez Rosso Argentina 15 117 0.5× 196 1.2× 67 0.6× 135 1.2× 110 1.3× 39 565

Countries citing papers authored by Yumi Jimbu

Since Specialization
Citations

This map shows the geographic impact of Yumi Jimbu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yumi Jimbu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yumi Jimbu more than expected).

Fields of papers citing papers by Yumi Jimbu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yumi Jimbu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yumi Jimbu. The network helps show where Yumi Jimbu may publish in the future.

Co-authorship network of co-authors of Yumi Jimbu

This figure shows the co-authorship network connecting the top 25 collaborators of Yumi Jimbu. A scholar is included among the top collaborators of Yumi Jimbu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yumi Jimbu. Yumi Jimbu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Daimon, Makoto, Tomoyoshi Soga, Atsushi Hozawa, et al.. (2012). Serum Glycerophosphate Levels are Increased in Japanese Men with Type 2 Diabetes. Internal Medicine. 51(6). 545–551. 7 indexed citations
2.
Oizumi, Toshihide, Makoto Daimon, Shigeru Karasawa, et al.. (2011). Assessment of plasma glucose cutoff values to predict the development of type 2 diabetes in a Japanese sample: the Funagata Study. Diabetology International. 2(1). 26–31. 2 indexed citations
3.
Daimon, Makoto, Toshihide Oizumi, Shigeru Karasawa, et al.. (2010). Association of the clusterin gene polymorphisms with type 2 diabetes mellitus. Metabolism. 60(6). 815–822. 45 indexed citations
4.
Daimon, Makoto, Toshihide Oizumi, Sayumi Toriyama, et al.. (2009). Association of the Ser326Cys polymorphism in the OGG1 gene with type 2 DM. Biochemical and Biophysical Research Communications. 386(1). 26–29. 30 indexed citations
5.
Cui, Can, Hiroshi Ohnuma, Makoto Daimon, et al.. (2008). Ghrelin infused into the portal vein inhibits glucose-stimulated insulin secretion in Wistar rats. Peptides. 29(7). 1241–1246. 30 indexed citations
6.
Lü, Yan, Yumi Jimbu, Joseph C. Y. Chen, et al.. (2008). The Effects of Rosiglitazione on Renal Artery Endothelium in Diabetic Rats. Experimental and Clinical Endocrinology & Diabetes. 116(9). 537–540. 6 indexed citations
7.
Igarashi, Masahiko, Akihiko Hirata, Hiroshi Yamaguchi, Yumi Jimbu, & Makoto Tominaga. (2008). Pioglitazone Reduces Atherogenic Outcomes in Type 2 Diabetic Patients. Journal of Atherosclerosis and Thrombosis. 15(1). 34–40. 19 indexed citations
8.
Daimon, Makoto, Hidenori Sato, Satoshi Sasaki, et al.. (2008). Salt consumption-dependent association of the GNB3 gene polymorphism with type 2 DM. Biochemical and Biophysical Research Communications. 374(3). 576–580. 24 indexed citations
9.
Oizumi, Toshihide, Makoto Daimon, Yumi Jimbu, et al.. (2008). Impaired glucose tolerance is a risk factor for stroke in a Japanese sample—the Funagata study. Metabolism. 57(3). 333–338. 40 indexed citations
10.
Susa, Shinji, Makoto Daimon, Jun‐ichi Sakabe, et al.. (2008). A functional polymorphism of the TNF-α gene that is associated with type 2 DM. Biochemical and Biophysical Research Communications. 369(3). 943–947. 19 indexed citations
11.
Igarashi, Masahiko, et al.. (2007). Effect of pioglitazone on atherogenic outcomes in type 2 diabetic patients: A comparison of responders and non-responders. Diabetes Research and Clinical Practice. 77(3). 389–398. 13 indexed citations
12.
Igarashi, Masahiko, et al.. (2007). Characterization of Activation of MAP Kinase Superfamily in Vasculature from Diabetic Rats. Journal of Atherosclerosis and Thrombosis. 14(5). 235–244. 12 indexed citations
13.
Daimon, Makoto, Hidenori Sato, Toshihide Oizumi, et al.. (2007). Association of the PIK3C2G gene polymorphisms with type 2 DM in a Japanese population. Biochemical and Biophysical Research Communications. 365(3). 466–471. 54 indexed citations
14.
Oizumi, Toshihide, Makoto Daimon, Yumi Jimbu, et al.. (2007). A Palatinose-Based Balanced Formula Improves Glucose Tolerance, Serum Free Fatty Acid Levels and Body Fat Composition. The Tohoku Journal of Experimental Medicine. 212(2). 91–99. 24 indexed citations
15.
Daimon, Makoto, Toshihide Oizumi, Yumi Jimbu, et al.. (2006). Correlation between change in body weight rather than current body weight and change in serum adiponectin levels in a Japanese population—the Funagata study. Metabolism. 55(3). 324–330. 14 indexed citations
16.
Kameda, Wataru, Makoto Daimon, Toshihide Oizumi, et al.. (2005). Association of decrease in serum dehydroepiandrosterone sulfate levels with the progression to type 2 diabetes in men of a Japanese population: The Fungata Study. Metabolism. 54(5). 669–676. 35 indexed citations
17.
Daimon, Makoto, Takashi Kido, Masanori Baba, et al.. (2005). Association of the ABCA1 gene polymorphisms with type 2 DM in a Japanese population. Biochemical and Biophysical Research Communications. 329(1). 205–210. 34 indexed citations
18.
Yamaguchi, Hiroshi, Masahiko Igarashi, Akihiko Hirata, et al.. (2004). Progression of Diabetic Nephropathy Enhances the Plasma Osteopontin Level in Type 2 Diabetic Patients. Endocrine Journal. 51(5). 499–504. 56 indexed citations
19.
Igarashi, Masahiko, Akihiko Hirata, Toshiyuki Yamauchi, et al.. (2003). Clinical Utility and Approach to Estimate Postprandial Hypertriglycemia by A Newly Designed Oral Fat-loading Test. Journal of Atherosclerosis and Thrombosis. 10(5). 314–320. 16 indexed citations
20.
Igarashi, Masahiko, Akihiko Hirata, Hiroshi Yamaguchi, et al.. (2003). Mechanism of an Inhibitory Effect of nipradilol on Rat Vascular Smooth Muscle Cell Growth.. Journal of Atherosclerosis and Thrombosis. 10(4). 226–233. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kikuko Amo Breakdown of academic impact, for papers by Mizuko Osaka Breakdown of academic impact, for papers by Laura A. Villalobos Breakdown of academic impact, for papers by Cecilia Vitali Breakdown of academic impact, for papers by Richard Reneland Breakdown of academic impact, for papers by Danielle Lann Breakdown of academic impact, for papers by Taishan Zheng Breakdown of academic impact, for papers by Dalia El-Lebedy Breakdown of academic impact, for papers by Naoyuki Iso-O Breakdown of academic impact, for papers by Leonardo Gómez Rosso
Rankless by CCL
2026